Mohamed Chairi Mohamed H, Mogollón González Mónica, Triguero Cabrera Jennifer, Segura Jiménez Inmaculada, Villegas Herrera Maria T, Villar Del Moral Jesús M
Transplant Surgery Division, Department of Surgery, Virgen de las Nieves University Hospital, Granada 18013, Andalusia, Spain.
World J Transplant. 2024 Dec 18;14(4):97612. doi: 10.5500/wjt.v14.i4.97612.
Liver grafts from donation after circulatory death (DCD) are associated with a higher risk of early graft dysfunction, determined by the warm ischemia and cold ischemia times. It is essential to have precise criteria to identify this complication in order to guide therapeutic strategies.
To validate different graft and recipient survival scores in patients undergoing liver transplantation (LT) with DCD grafts.
A retrospective and observational unicentric study was conducted on 65 LT patients with grafts obtained from controlled DCD donors from November 2013 to November 2022. The United Kingdom (UK) risk score, early allograft dysfunction (EAD) Olthoff score, and model for early allograft function (MEAF) score were used to evaluate the risk of graft and recipient survival post-transplant. For survival analysis purposes, we used the Kaplan-Meier method, and the differences between subgroups were compared using the log-rank (Mantel-Cox) test.
Sixty-five patients were included in the study. The UK risk score did not demonstrate predictive capacity for recipient or graft survival. However, in donors aged over 70 years old (18.4%), it significantly predicted graft survival ( < 0.05). According to Kaplan-Meier survival curves, graft survival rates at 6 months, 2 years, and 5 years in the futility group dramatically decreased to 50% compared to the other groups (log-rank 8.806, < 0.05). The EAD Olthoff and MEAF scores did not demonstrate predictive capacity for recipient or graft survival. Based on Kaplan-Meier survival curves, patients with a MEAF score ≥ 7 had a lower graft survival rate at 6 months, 2 years, and 5 years compared to patients with a lower MEAF score (log-rank 4.667, < 0.05).
In our series, both UK DCD risk score and MEAF score showed predictive capability for graft survival.
循环死亡后捐赠(DCD)的肝移植与早期移植物功能障碍的较高风险相关,这由热缺血和冷缺血时间决定。拥有精确的标准来识别这种并发症对于指导治疗策略至关重要。
验证接受DCD移植物的肝移植(LT)患者中不同的移植物和受者生存评分。
对2013年11月至2022年11月期间65例接受来自受控DCD供者移植物的LT患者进行了一项回顾性单中心观察研究。使用英国(UK)风险评分、早期移植物功能障碍(EAD)奥尔托夫评分和早期移植物功能模型(MEAF)评分来评估移植后移植物和受者生存的风险。为了进行生存分析,我们使用了Kaplan-Meier方法,并使用对数秩(Mantel-Cox)检验比较亚组之间的差异。
65例患者纳入研究。UK风险评分未显示出对受者或移植物生存的预测能力。然而,在70岁以上的供者(18.4%)中,它显著预测了移植物生存(<0.05)。根据Kaplan-Meier生存曲线,与其他组相比,无意义组6个月、2年和5年的移植物生存率急剧下降至50%(对数秩8.806,<0.05)。EAD奥尔托夫评分和MEAF评分未显示出对受者或移植物生存的预测能力。基于Kaplan-Meier生存曲线,MEAF评分≥7的患者在6个月、2年和5年时的移植物生存率低于MEAF评分较低的患者(对数秩4.667,<0.05)。
在我们的系列研究中,UK DCD风险评分和MEAF评分均显示出对移植物生存的预测能力。